OPINION | Making the business of HIV/Aids everyone’s business

accreditation
Share your Subscriber Article
You have 5 articles to share every month. Send this story to a friend!
0:00
play article
Subscribers can listen to this article
Several studies have been published on the economic benefits of a well-coordinated workplace ARV treatment interventions.
Several studies have been published on the economic benefits of a well-coordinated workplace ARV treatment interventions.
iStock

Workplace ARV provision is not just ethically sound, it can be cost-saving for companies in high-HIV-prevalence settings, says Mpumi Zikalala.

Support independent journalism
Subscribe to News24 for just R75 per month to read all our investigative and in-depth journalism.
Subscribe
Already a subscriber? Sign in
Rand - Dollar
14.29
+0.4%
Rand - Pound
19.75
+0.3%
Rand - Euro
16.95
+0.7%
Rand - Aus dollar
10.70
+0.6%
Rand - Yen
0.13
+0.7%
Gold
1,764.62
0.0%
Silver
25.81
0.0%
Palladium
2,467.49
0.0%
Platinum
1,038.50
0.0%
Brent Crude
73.51
+0.6%
Top 40
59,504
-1.5%
All Share
65,635
-1.4%
Resource 10
60,958
-1.7%
Industrial 25
87,956
-1.3%
Financial 15
12,995
-2.0%
All JSE data delayed by at least 15 minutes Iress logo
Company Snapshot
Voting Booth
Should government have assigned a majority shareholding in SAA to the private sector?
Please select an option Oops! Something went wrong, please try again later.
Results
Yes, It's a good decision
64% - 156 votes
Not a good move
9% - 23 votes
Too early to tell
27% - 66 votes
Vote